AECOM enters the week after a punishing earnings selloff with one clear new signal: the CEO and CFO bought stock in the wreckage.
On May 14, CEO Troy Rudd purchased 4,225 shares at $71.02, spending roughly $300,000. CFO Gaurav Kapoor added 1,420 shares at $71.12, committing just over $100,000. Both trades were open-market purchases made in the days after the stock's 13% single-day collapse on May 12 following the Q2 earnings miss. The net insider position over the past 90 days has turned marginally positive at just over $400,000 in net value. It isn't large relative to the losses that preceded it — but the CEO and CFO buying together at the low, with real cash, is a qualitatively different signal than routine compensation-linked transactions. The last notable insider activity before this was the president and CEO selling near $97 in December; the gap between those sale prices and today's $71.18 close tells its own story.
The broader positioning setup is less charged than last week's post-earnings scramble. Short interest has climbed roughly 37% over the past month to 5.0% of free float — a meaningful accumulation — but the borrow market shows no stress. Cost to borrow is just 0.44%, near a 30-day low, and availability is running at over 2,400%, meaning shares are plentiful relative to the existing short base. That combination — rising short interest with ample, cheap borrow — points to a deliberate, low-friction short thesis rather than a forced or crowded trade. Short interest ticked down about 1.6% on May 19 after topping out mid-week, suggesting some shorts are already trimming. The ORTEX short score of 42.5 sits in only the 26th percentile for its sector, reinforcing that this isn't a heavily shorted name in relative terms. Options, meanwhile, have settled back toward neutral: the put/call ratio at 0.44 is marginally below its 20-day average of 0.46 — call demand is fractionally dominant, consistent with dip-buying interest after the selloff rather than any new defensive positioning.
The Street remains broadly constructive but has sharply reduced its near-term price expectations. After the earnings miss, Citigroup cut its target from $130 to $98 while keeping Buy, RBC Capital slashed from $142 to $111 (Outperform), and Truist Securities trimmed from $116 to $109 (Buy). Barclays, which had been neutral, cut from $110 to $90 on May 19 — the latest and most cautious move. The consensus mean target now sits at $106.88, implying around 50% upside from current levels. That gap is a product of how far the stock has fallen rather than a fresh upgrade cycle. The factor picture is mixed: analyst recommendation dispersion ranks in the 91st percentile, reflecting unusually wide disagreement between bulls and bears. Forward EPS growth still scores in the 76th percentile for year-on-year increases, and the dividend score ranks at the top of the universe — though dividend payments appear to have paused after mid-2022 based on the available history. Valuation has compressed hard: the P/E is now 11.4x, down nearly 2.7 turns over the past 30 days, and EV/EBITDA has eased to 8.3x.
The bull case, as articulated by the Buy-rated firms, centres on organic margin expansion, a strong project backlog, and accelerating US defence-related revenue. The bear case focuses on Middle East headwinds slowing international markets, AI-related investment costs pressuring second-half margins, and negative free cash flow. Those debates were visible before May 11; the earnings print sharpened them. Correlated peers STN and WSP were both down 7.5% and 6.2% respectively on the week, suggesting sector-wide pressure rather than ACM-specific idiosyncratic selling — though ACM's post-earnings drop was still far more severe than either peer's weekly move.
The next meaningful data point is whether the insider buying attracts follow-on support from institutional holders or remains an isolated signal. BlackRock holds 12.3% of shares and added over 550,000 shares as of April 30; how the larger holders respond to this price level will be worth tracking in the next round of 13-F filings.
See the live data behind this article on ORTEX.
Open ACM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
